(lp0
S'Analyst Upgrades  Vertex Pharmaceuticals Incorporated  Stock ... Market Exclusive - Mar 17, 2017 Today, Vertex Pharmaceuticals Incorporated  stock received an upgrade by JMP Securities from Outperform. There are 11 hold ratings, 13 buy ratings on the stock.57 hedge funds buy Vertex Pharmaceuticals Incorporated  for the first time - Post AnalystJMP Securities Upgrades Vertex Pharmaceuticals Incorporated  to Mkt ... - Chaffey Breeze'
p1
aS'Zacks.com featured highlights: Covanta Holding, Etsy, PTC, Incyte and Vertex ... Yahoo Finance - Mar 16, 2017 Boston, MA-based, Vertex Pharmaceuticals Incorporated  is a bio-technology company. Over the past one-month period, current quarter estimates moved up from 2 cents per share to 4 cents.'
p2
aS'Vertex Pharmaceuticals: Avoid This Cash Vortex Seeking Alpha - Feb 23, 2017 It seems that the only things that have grown at a relatively predictable and constant rate at Vertex Pharmaceuticals  are the R&amp;D expenses and the share count.Vertex Pharmaceuticals Incorporated  Position Increased by Federated ... - The Cerbat GemToday Analysts Focus on Tiffany &amp; Co. , Vertex Pharmaceuticals ... - StockNewsJournal'
p3
aS"Vertex's Cystic Fibrosis Strategy In Tune With Concert Buy Seeking Alpha - Mar 7, 2017 At first glance, Vertex Pharmaceuticals  appears to have paid more than enough for Concert Pharmaceuticals'  CTP-656, a once-daily version of its marketed therapy Kalydeco.VERTEX PHARMACEUTICALS INCORPORATED  Files An 8-K Entry into a ... - Market ExclusiveVertex to Buy Concert's Cystic Fibrosis Candidate for $160M - Zacks.com"
p4
aS"Vertex's $160M Deal With Concert Pharmaceuticals Seeking Alpha - Mar 9, 2017 This week began with Vertex Pharmaceuticals Incorporated  announcing a deal to buy the development and commercialization rights of Concert Pharmaceuticals'  cystic fibrosis pipeline candidate, CTP-656 for a cost of&nbsp;..."
p5
aS'Vertex Pharmaceuticals Incorporated  Upgraded at Vetr Inc. BNB Daily  - Mar 13, 2017 Vertex Pharmaceuticals Incorporated logo Vetr upgraded shares of Vertex Pharmaceuticals Incorporated  from a buy rating to a strong-buy rating in a report issued on Tuesday morning.Vertex Pharmaceuticals Incorporated  Raised to Buy at Vetr Inc. - The Cerbat Gem'
p6
aS'Vertex Pharmaceuticals Incorporated  Short Interest Update Chaffey Breeze - Mar 12, 2017 Vertex Pharmaceuticals logo Vertex Pharmaceuticals Incorporated  saw a significant decline in short interest in the month of February.'
p7
aS'Vertex Pharmaceuticals Incorporated  Receives Consensus Rating of Hold ... BNB Daily  - Mar 11, 2017 Vertex Pharmaceuticals logo Vertex Pharmaceuticals Incorporated  has been given an average rating of Hold by the twenty-seven research firms that are presently covering the company.'
p8
aS"Let's Get Technical With Vertex Pharmaceuticals Incorporated  USA Commerce Daily - Mar 17, 2017 With all other things going on, Vertex Pharmaceuticals Incorporated  has been on a run - rising 20.57 percent in just three months."
p9
aS'Does These Stocks Deserve Your Investment Dollars?  Vertex Pharmaceuticals ... USA Commerce Daily - Mar 16, 2017 Shares of Vertex Pharmaceuticals Incorporated  are on a recovery track as they have regained 32.34% since bottoming out at $71.46 on Dec. 22, 2016.'
p10
a.